Skip to main content
Equibles

James M. Daly

Board Member

Acadia Pharmaceuticals Inc (ACAD)

Board Member

Madrigal Pharmaceuticals, Inc. (MDGL)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James M. Daly

James M. Daly is recorded as Board Member at Acadia Pharmaceuticals Inc (ACAD) and Board Member at Madrigal Pharmaceuticals, Inc. (MDGL). Earlier roles on record: Board Member at Halozyme Therapeutics, Inc. (HALO) until December 31, 2023. Acadia Pharmaceuticals Inc reported in an 8-K filed May 29, 2026 that James M. Daly was appointed Class I director, effective May 29, 2026. Halozyme Therapeutics, Inc. reported in an 8-K filed February 23, 2023 that James M. Daly resigned as member of the Board of Directors, effective December 31, 2023.

“The following three Class I directors were elected by the votes indicated:”
Acadia Pharmaceuticals Inc Form 8-K, filed May 29, 2026 · Read the filing
“On February 22, 2023, James M. Daly, a member of the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”), notified the Company of his intention to resign from the Company’s Board of Directors effective at the end of the 2023 calendar year.”
Halozyme Therapeutics, Inc. Form 8-K, filed February 23, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Acadia Pharmaceuticals Inc

Other people whose current roles at this company are on record from its filings.

Leadership on record at Madrigal Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.